Israil Anca, Balotescu Carmen, Bucurenci Nadia, Năcescu Nadia, Cedru Claudia, Popa Cornelia, Ciufecu C
1-N.I.R.D.M.I. "Cantacuzino", 2 - Hospital of Ophthalmologic Emergency - Bucharest, Romania.
Roum Arch Microbiol Immunol. 2003 Jul-Dec;62(3-4):155-77.
Four hundred ninety seven strains of Vibrio cholerae selected from isolates in Romania in the last decade 1990-1999 were investigated for antibiotic resistance and for classical and putative virulence factors. V. cholerae O1 strains predominated in clinical cases and non O1 strains in the environment, excepting in 1992 when non O1 strains were frequent in clinical and environmental sources. V. cholerae O1 strains previously susceptible to tetracycline acquired clinically significant resistance to this drug during 1993-1994, but this trend was reversed in 1995, following the introduction of nalidixic acid in cholera treatment in 1994. V. cholerae O1 and non O1 clinical isolates acquired simultaneous resistance to the vibriostatic agent O/129 and cotrimoxazole during 1994-1995. High levels of intrinsic resistance to multiple antibiotics were exhibited by all strains examined. The presence of cholera toxin (CT) was concentrated in clinical V. cholerae O1 strains and was substituted in clinical non O1 strains by four putative virulence markers (Kanagawa haemolysin, slime, lipase, and colonial opacity). Colonial opacity (30%) was present only in clinical isolates of V. cholerae non O1. Pigmentogenesis (11.7%) has present only in environmental sources. Antibioresistance profiles differ for V. cholerae O1 and non O1 strains with respect to their source of isolation. This aspect may imply a role in virulence and survival of V. cholerae in the natural environment where they may serve as a reservoir of virulence and multiple drug resistance genes.
对1990年至1999年这十年间从罗马尼亚分离出的497株霍乱弧菌进行了抗生素耐药性以及经典和假定毒力因子的研究。霍乱弧菌O1菌株在临床病例中占主导,非O1菌株在环境中占主导,但1992年除外,当时非O1菌株在临床和环境来源中都很常见。以前对四环素敏感的霍乱弧菌O1菌株在1993年至1994年期间获得了对该药物具有临床意义的耐药性,但在1994年霍乱治疗中引入萘啶酸后,这种趋势在1995年发生了逆转。1994年至1995年期间,霍乱弧菌O1和非O1临床分离株同时获得了对弧菌抑制剂O/129和复方新诺明的耐药性。所有检测菌株都表现出对多种抗生素的高水平固有耐药性。霍乱毒素(CT)的存在集中在临床霍乱弧菌O1菌株中,而在临床非O1菌株中被四种假定的毒力标记物(神奈川溶血素、黏液、脂肪酶和菌落不透明性)所取代。菌落不透明性(30%)仅存在于霍乱弧菌非O1的临床分离株中。色素生成(11.7%)仅存在于环境来源中。霍乱弧菌O1和非O1菌株的抗药谱因其分离来源而异。这方面可能意味着霍乱弧菌在自然环境中的毒力和生存中发挥作用,在自然环境中它们可能作为毒力和多重耐药基因的储存库。